Prot# C-447: A Phase I Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Assessment of CG53135-05 Administered Intravenously in Patients with Oral Mucositis After Receiving Autologous Stem Cell Transplant (Multiple Rising-Dose Tolera